Can MRK’s New Drugs Drive Long-Term Growth Amid Looming Keytruda LOE?
Merck MRK faces a looming patent cliff as its blockbuster PD-L1, Keytruda, approaches loss of exclusivity (LOE) in 2028. The drug...
Merck MRK faces a looming patent cliff as its blockbuster PD-L1, Keytruda, approaches loss of exclusivity (LOE) in 2028. The drug...
WINNIPEG, MB and TORONTO, Aug. 28, 2025 /CNW/ - As part of its ongoing commitment to deliver leading-edge solutions and services...
What Is Trend Analysis? Trend analysis is a technique used in technical analysis that attempts to predict future stock price...
The Employee Rights Bill has been in the news again recently following the resignation of Angela Rayner. The former deputy...
An updated edition of the July 28, 2025, article.Founders hold a unique ability to shape and grow a company from...
On September 10, 2025, American Express and UPS announced an expanded agreement giving small and medium-sized businesses exclusive shipping discounts...